Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Influenza and Other Respiratory Viruses|August 14, 2020
A COVID-19 human viral challenge model. Learning from experienceRob Lambkin-Williams, John P DeVincenzoSAGE Open Medicine|October 8, 2020
Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell lineRob Lambkin-Williams, Alex Mann, Adrian ShephardThe Pediatric Infectious Disease Journal|December 27, 2005
Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesisJohn P DeVincenzoThe Pediatric Infectious Disease Journal|October 23, 2008
RNA interference strategies as therapy for respiratory viral infectionsJohn P DeVincenzoThe New England Journal of Medicine|November 19, 2015
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge StudyJohn P DeVincenzo, Matthew W McClure, Julian A Symons, et al.Pediatric Research|October 8, 2004
Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral loadJohn P DevincenzoAntiviral Therapy|February 8, 2012
The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory virusesJohn P DeVincenzoEarly Human Development|October 17, 2009
Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trialsJohn P DeVincenzoClinical Microbiology Reviews|October 16, 2008
Human genetic factors and respiratory syncytial virus disease severityIsao Miyairi, John P DeVincenzoRespiratory Research|June 23, 2018
The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnosticsRob Lambkin-Williams, Nicolas Noulin, Alex Mann, et al.Pageof 9